Carteolol Hydrochloride

盐酸卡替洛尔

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCarteolol Hydrochloride
Drug Alias NameCarteololum盐酸喹酮心安卡替诺尔喹酮心安盐酸卡特洛尔 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor agonistsBeta-2 adrenergic receptor antagonists
TargetsBeta-2 adrenergic receptorBeta-1 adrenergic receptor
Therapy Area/IndicationsHypertensionAngina PectorisArrhythmias, Cardiac +[5] 
Global Approved IndicationsHypertensionAngina PectorisArrhythmias, Cardiac +[5] 
Approved Indications in ChinaGlaucomaOcular Hypertension
Original Approved Country/TerritoryJapan
Original Approved Date1980/10/25
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbvie IncOtsuka Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Pharmaceutical Co LtdChina Otsuka Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionAngina PectorisArrhythmias, Cardiac +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeC07AA15S01ED05
Related LinksWikipediaDrugBankKEGG